Franklin Resources’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $469M | Buy |
2,051,948
+141,869
| +7% | +$31.8M | 0.11% | 177 |
|
|
2025
Q4 | $407M | Buy |
1,910,079
+320,123
| +20% | +$66.1M | 0.1% | 198 |
|
|
2025
Q3 | $316M | Sell |
1,589,956
-163,512
| -9% | -$30.5M | 0.08% | 233 |
|
|
2025
Q2 | $303M | Buy |
1,753,468
+113,347
| +7% | +$18.5M | 0.08% | 238 |
|
|
2025
Q1 | $256M | Buy |
1,640,121
+283,704
| +21% | +$40.5M | 0.07% | 253 |
|
|
2024
Q4 | $187M | Sell |
1,356,417
-103,306
| -7% | -$13.6M | 0.05% | 315 |
|
|
2024
Q3 | $188M | Sell |
1,459,723
-625,128
| -30% | -$84.4M | 0.05% | 312 |
|
|
2024
Q2 | $284M | Buy |
2,084,851
+102,982
| +5% | +$14M | 0.09% | 231 |
|
|
2024
Q1 | $300M | Buy |
1,981,869
+917,064
| +86% | +$131M | 0.09% | 227 |
|
|
2023
Q4 | $134M | Sell |
1,064,805
-148,480
| -12% | -$14.8M | 0.06% | 307 |
|
|
2023
Q3 | $114M | Sell |
1,213,285
-40
| -0% | -$3.74K | 0.06% | 331 |
|
|
2023
Q2 | $108M | Sell |
1,213,325
-132,579
| -10% | -$11.5M | 0.05% | 349 |
|
|
2023
Q1 | $144M | Sell |
1,345,904
-31,618
| -2% | -$3.62M | 0.07% | 304 |
|
|
2022
Q4 | $168M | Buy |
1,377,522
+223,430
| +19% | +$25.9M | 0.09% | 267 |
|
|
2022
Q3 | $119M | Buy |
1,154,092
+196,055
| +20% | +$18.6M | 0.06% | 339 |
|
|
2022
Q2 | $89.1M | Buy |
958,037
+36,356
| +4% | +$3.43M | 0.04% | 408 |
|
|
2022
Q1 | $108M | Buy |
921,681
+2,268
| +0.2% | +$263K | 0.04% | 414 |
|
|
2021
Q4 | $124M | Buy |
919,413
+89,702
| +11% | +$13.3M | 0.04% | 411 |
|
|
2021
Q3 | $132M | Buy |
829,711
+35,448
| +4% | +$4.85M | 0.05% | 385 |
|
|
2021
Q2 | $104M | Buy |
794,263
+61,888
| +8% | +$8.25M | 0.04% | 460 |
|
|
2021
Q1 | $94.4M | Buy |
732,375
+312
| +0% | +$47.4K | 0.04% | 445 |
|
|
2020
Q4 | $122M | Buy |
732,063
+16,630
| +2% | +$2.75M | 0.05% | 368 |
|
|
2020
Q3 | $110M | Buy |
715,433
+17,390
| +2% | +$2.5M | 0.05% | 356 |
|
|
2020
Q2 | $99.5M | Sell |
698,043
-2,117
| -0.3% | -$291K | 0.05% | 368 |
|
|
2020
Q1 | $78.8M | Sell |
700,160
-118,582
| -14% | -$15.4M | 0.05% | 349 |
|
|
2019
Q4 | $114M | Sell |
818,742
-59,492
| -7% | -$6.61M | 0.06% | 346 |
|
|
2019
Q3 | $84.6M | Buy |
878,234
+330
| +0% | +$36.8K | 0.05% | 404 |
|
|
2019
Q2 | $101M | Sell |
877,904
-283
| -0% | -$33.9K | 0.05% | 375 |
|
|
2019
Q1 | $103M | Buy |
878,187
+257,589
| +42% | +$22.6M | 0.06% | 349 |
|
|
2018
Q4 | $38.9M | Buy |
620,598
+28,700
| +5% | +$1.8M | 0.02% | 541 |
|
|
2018
Q3 | $41.9M | Buy |
591,898
+42,800
| +8% | +$2.95M | 0.02% | 587 |
|
|
2018
Q2 | $36.5M | Buy |
549,098
+47,931
| +10% | +$3.15M | 0.02% | 611 |
|
|
2018
Q1 | $32.8M | Buy |
+501,167
| New | +$28.2M | 0.02% | 650 |
|
Other funds holding ASND
RCM
ACA
PA
Franklin Resources's ASND Position: Q1 2026 in Review
Franklin Resources increased its Ascendis Pharma A/S (ASND) stake by 7.4% in Q1 2026, buying an estimated $31.8M and bringing the position to 2,051,948 shares worth $469M. The position accounts for 0.11% of the portfolio, ranked #177.
Franklin Resources first reported a position in ASND in Q1 2018 and has held it in 33 quarters since. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.
- Franklin Resources held 2,051,948 shares of Ascendis Pharma A/S worth $469M as of Q1 2026.
- Franklin Resources bought 141,869 Ascendis Pharma A/S shares in Q1 2026, an estimated $31.8M.
- Ascendis Pharma A/S made up 0.11% of Franklin Resources's portfolio in Q1 2026, its #177 holding.
- Franklin Resources first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 33 quarters since.
- 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.
Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.